InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
19
T+90 hit rate
50%
T+90 mean return
-9.9%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Jiang Wenbin. Director active across 1 company, notably Cytek Biosciences, Inc.. Aggregated, 42 reports have been published. Split: 0 buy · 19 sells. Total volume traded: €3.7m. History available since 4 December 2021. The latest transaction was disclosed on 14 September 2024 (Don). Regulator: SEC (Form 4). The full history is free.
Declarations42 total
6,758 sharesCommon StockSEC:0001415889-25-013982:0
15,708 sharesCommon StockSEC:0001415889-25-007889:0
6,758 sharesCommon StockSEC:0001415889-25-004924:0
6,758 sharesCommon StockSEC:0001415889-24-027367:0
200,000 shares0Common StockSEC:0001415889-24-023460:0
6,758 sharesCommon StockSEC:0001415889-24-021858:0
6,758 sharesCommon StockSEC:0001415889-24-014146:0
15,708 sharesCommon StockSEC:0001415889-24-007865:0
6,758 sharesCommon StockSEC:0001415889-24-004895:0
6,758 sharesCommon StockSEC:0001209191-23-056348:0
20,000 shares@ US$4.342.2% of flowCommon StockSEC:0001209191-23-054731:0
20,000 shares@ US$5.332.7% of flowCommon StockSEC:0001209191-23-052657:0
2,290,000 shares0Common StockSEC:0001209191-23-052263:0
20,000 shares@ US$6.833.4% of flowCommon StockSEC:0001209191-23-048847:0
6,758 sharesCommon StockSEC:0001209191-23-046832:0
20,000 shares@ US$9.044.4% of flowCommon StockSEC:0001209191-23-045099:0
20,000 shares@ US$8.484.2% of flowCommon StockSEC:0001209191-23-041867:0
20,000 shares@ US$8.234.1% of flowCommon StockSEC:0001209191-23-035222:0
6,758 sharesCommon StockSEC:0001209191-23-031262:0
20,000 shares@ US$11.555.6% of flowCommon StockSEC:0001209191-23-028568:0
20,000 shares@ US$8.884.4% of flowCommon StockSEC:0001209191-23-024043:0
20,000 shares@ US$10.135.1% of flowCommon StockSEC:0001209191-23-016979:0
6,758 sharesCommon StockSEC:0001209191-23-012356:0
20,000 shares@ US$13.196.6% of flowCommon StockSEC:0001209191-23-007911:0
20,000 shares@ US$10.665.4% of flowCommon StockSEC:0001209191-23-002859:0
25 of 42 declarations
About Jiang Wenbin
Jiang Wenbin is a director at Cytek Biosciences, Inc.
